• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

渗透性血脑屏障破坏:犬类药效学研究及恶性脑肿瘤患者的临床I期试验

Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors.

作者信息

Neuwelt E A, Hill S A, Frenkel E P, Diehl J T, Maravilla K R, Vu L H, Clark W K, Rapoport S I, Barnett P A, Lewis S E, Ehle A L, Beyer C W

出版信息

Cancer Treat Rep. 1981;65 Suppl 2:39-43.

PMID:6809316
Abstract

Infusion of 25% mannitol in saline into the internal carotid artery of dogs disrupts the blood-brain barrier (BBB) in a controlled and reproducible manner (osmotic disruption), whereas mannitol infused through the common carotid artery produces variable disruption of the BBB. Compared to controls, infusion of methotrexate in dogs after osmotic disruption produced significantly higher drug levels in brain. We report very preliminary data on the effects of osmotic disruption with mannitol in five patients harboring malignant brain tumors.

摘要

向狗的颈内动脉输注25%的甘露醇生理盐水能以可控且可重复的方式(渗透性破坏)破坏血脑屏障(BBB),而通过颈总动脉输注甘露醇对血脑屏障的破坏则具有变异性。与对照组相比,在渗透性破坏后向狗输注甲氨蝶呤可使脑内药物水平显著升高。我们报告了关于甘露醇渗透性破坏对五例患有恶性脑肿瘤患者影响的非常初步的数据。

相似文献

1
Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors.渗透性血脑屏障破坏:犬类药效学研究及恶性脑肿瘤患者的临床I期试验
Cancer Treat Rep. 1981;65 Suppl 2:39-43.
2
Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.脑淋巴瘤患者经渗透性血脑屏障破坏后脑脊液和血清中甲氨蝶呤的药代动力学
Clin Pharmacol Ther. 2000 Jun;67(6):631-41. doi: 10.1067/mcp.2000.106932.
3
[Intra-arterial chemotherapy of malignant glioma after osmotic blood-brain barrier disruption].[渗透性血脑屏障破坏后恶性胶质瘤的动脉内化疗]
Gan To Kagaku Ryoho. 1989 Aug;16(8 Pt 2):2692-6.
4
Blood-brain barrier disruption and methotrexate in the treatment of a readily transplantable intracerebral osteogenic sarcoma of rats.血脑屏障破坏与甲氨蝶呤治疗大鼠易移植性脑内骨肉瘤
Cancer Res. 1987 Dec 1;47(23):6225-8.
5
Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors.恶性脑肿瘤化疗中血脑屏障的改变
Fed Proc. 1984 Feb;43(2):214-9.
6
Intracarotid infusion of hypertonic mannitol changes permeability of blood-brain barrier to methotrexate in rats.大鼠颈内动脉输注高渗甘露醇会改变血脑屏障对甲氨蝶呤的通透性。
Acta Pharmacol Sin. 2000 Jul;21(7):613-6.
7
[ACNU delivery to malignant glioma tissue by osmotic blood brain barrier modification with intracarotid infusion of hyperosmoral mannitol].[通过颈动脉内输注高渗甘露醇进行渗透性血脑屏障修饰将ACNU递送至恶性胶质瘤组织]
No Shinkei Geka. 1985 Sep;13(9):955-63.
8
The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.硫酸镁对大鼠颈内动脉注射高渗甘露醇所致血脑屏障破坏的影响。
Life Sci. 2004 Nov 26;76(2):201-12. doi: 10.1016/j.lfs.2004.07.012.
9
Osmotic blood-brain barrier disruption: a new means of increasing chemotherapeutic agent delivery.渗透性血脑屏障破坏:一种增加化疗药物递送的新方法。
Trans Am Neurol Assoc. 1979;104:256-60.
10
[Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas].[恶性胶质瘤化疗中血脑屏障的可逆性开放]
Wien Klin Wochenschr. 1987 May 29;99(11):385-8.

引用本文的文献

1
Status Quo and Trends of Intra-Arterial Therapy for Brain Tumors: A Bibliometric and Clinical Trials Analysis.脑肿瘤动脉内治疗的现状与趋势:文献计量学与临床试验分析
Pharmaceutics. 2021 Nov 6;13(11):1885. doi: 10.3390/pharmaceutics13111885.
2
Strategies for Improved Intra-arterial Treatments Targeting Brain Tumors: a Systematic Review.改善针对脑肿瘤的动脉内治疗的策略:一项系统综述。
Front Oncol. 2020 Aug 26;10:1443. doi: 10.3389/fonc.2020.01443. eCollection 2020.
3
Overcoming the blood-brain barrier in neurodegenerative disorders and brain tumours.
克服神经退行性疾病和脑肿瘤的血脑屏障。
IET Nanobiotechnol. 2020 Aug;14(6):441-448. doi: 10.1049/iet-nbt.2019.0351.
4
Biologically-derived nanomaterials for targeted therapeutic delivery to the brain.用于靶向脑部治疗递送的生物衍生纳米材料。
Sci Prog. 2018 Sep 1;101(3):273-292. doi: 10.3184/003685018X15306123582346. Epub 2018 Aug 2.
5
Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier.不断发展的药物递送策略以克服血脑屏障
Curr Pharm Des. 2016;22(9):1177-1193. doi: 10.2174/1381612822666151221150733.
6
Impact of drug size on brain tumor and brain parenchyma delivery after a blood-brain barrier disruption.药物粒径对血脑屏障破坏后脑肿瘤和脑实质递送的影响。
J Cereb Blood Flow Metab. 2014 May;34(5):820-6. doi: 10.1038/jcbfm.2014.14. Epub 2014 Feb 12.
7
Some aspects of size-dependent differential drug response in primary and metastatic tumors.原发性和转移性肿瘤中大小依赖性差异药物反应的一些方面。
Cancer Metastasis Rev. 1985;4(1):27-39. doi: 10.1007/BF00047735.